Delivery Order SPE2DR25D2206-SPE2DR26F9ER7
Award Date 12/5/25
Potential Completion Date 12/8/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $1,860.18. The contract is a firm fixed-price delivery order with an ultimate completion date of July 7, 2025, and was awarded on July 3, 2025 without a set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of 24,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, with a ceiling value of $2,363.30. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count packaging, valued at $2,254.12. This is a firm fixed-price delivery order with no set-aside designation, issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $70,439.09 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme supplement) in 100-count bottles. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price and an ultimate completion date of September 3, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency issued a delivery order valued at $14,994.54 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count packages. This firm fixed-price delivery order, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical will be supplied from the vendor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for 12,000 unit capsules of Creon (pancreatic enzyme supplement) in 100-unit bottles, with a ceiling value of $2,177.21 and an ultimate completion date of November 7, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of 36,000 unit capsules of Creon (a pancreatic enzyme replacement therapy) in 100-count bottles, with a contract ceiling value of $37,725.58. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $10,509.78 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of 36,000 unit capsules of Creon in 100-unit quantities. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,524.22 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles. The contract, executed on November 4, 2025, with completion targeted for November 5, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 12,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, with a ceiling value of $1,195.45. This is a firm fixed price delivery order with an ultimate completion date of October 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...